Genoks BRCA Test
The BRCA1 and BRCA2 genes play a critical role in DNA repair. Mutations in these genes are associated with a significantly increased risk of hereditary breast and ovarian cancer, as well as elevated risk of pancreatic and prostate cancer.
Who Should Consider BRCA Testing?
- Individuals with a personal or family history of breast or ovarian cancer at a young age
- Multiple cases of breast, ovarian, pancreatic or prostate cancer in the family
- Known BRCA mutation carriers in the family
- Individuals of Ashkenazi Jewish descent (higher founder mutation prevalence)
- Male family members with breast cancer
How the Test Works
Genoks BRCA testing uses Next-Generation Sequencing to analyze the full coding regions of BRCA1 and BRCA2, including detection of large deletions and duplications. Results are interpreted by Genoks specialists and delivered with a detailed report and access to genetic counseling.
What the Results Mean
A positive result identifies a pathogenic variant associated with elevated cancer risk and supports informed decisions about surveillance, prevention and treatment. A negative result reduces — but does not eliminate — risk based on family history. Variants of uncertain significance may require follow-up.
For genetic counseling and to learn whether BRCA testing is appropriate for you, please contact Genoks.